<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Acute coronary syndrome</title>
  <link rel="manifest" href="/manifest.json">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/semantic-ui/dist/semantic.min.css">
</head>
<body>
  <div class="ui stackable grid">
    <div class="four wide column">
      <ul>
        
          <li>
            <h3>兒科</h3>
            <ul>
              
                <li><a href="/pages/0-0.html">腫瘤學</a></li>
              
                <li><a href="/pages/0-1.html">兒童發展、疫苗</a></li>
              
                <li><a href="/pages/0-2.html">新生兒呼吸相關疾病</a></li>
              
                <li><a href="/pages/0-3.html">小兒腎臟學疾病</a></li>
              
                <li><a href="/pages/0-4.html">新生兒感染感染</a></li>
              
                <li><a href="/pages/0-5.html">圖庫資源</a></li>
              
                <li><a href="/pages/0-6.html">新生兒科</a></li>
              
                <li><a href="/pages/0-7.html">新生兒黃疸(Neonatal Jaundice)</a></li>
              
                <li><a href="/pages/0-8.html">新生兒評估(Newborn PE)</a></li>
              
                <li><a href="/pages/0-9.html">遺傳學</a></li>
              
                <li><a href="/pages/0-10.html">血液學</a></li>
              
                <li><a href="/pages/0-11.html">兒童過敏免疫風濕疾病</a></li>
              
                <li><a href="/pages/0-12.html">內分泌疾病</a></li>
              
                <li><a href="/pages/0-13.html">神經系統性疾病</a></li>
              
                <li><a href="/pages/0-14.html">感染科學</a></li>
              
                <li><a href="/pages/0-15.html">消化系統</a></li>
              
                <li><a href="/pages/0-16.html">腦及神經疾病</a></li>
              
                <li><a href="/pages/0-17.html">血管性疾病</a></li>
              
                <li><a href="/pages/0-18.html">惡性腫瘤</a></li>
              
                <li><a href="/pages/0-19.html">生殖泌尿道</a></li>
              
                <li><a href="/pages/0-20.html">先天腹壁異常</a></li>
              
                <li><a href="/pages/0-21.html">肝膽道疾病</a></li>
              
                <li><a href="/pages/0-22.html">腸胃道</a></li>
              
                <li><a href="/pages/0-23.html">頸部腫塊[CS]</a></li>
              
                <li><a href="/pages/0-24.html">體液、電解質及營養</a></li>
              
                <li><a href="/pages/0-25.html">創傷</a></li>
              
                <li><a href="/pages/0-26.html">兒外</a></li>
              
                <li><a href="/pages/0-27.html">心臟肺部血管系統</a></li>
              
                <li><a href="/pages/0-28.html">兒科基礎</a></li>
              
                <li><a href="/pages/0-29.html">兒內</a></li>
              
                <li><a href="/pages/0-30.html">編輯格式</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>內科</h3>
            <ul>
              
                <li><a href="/pages/1-0.html">Mallory-Weiss Tear</a></li>
              
                <li><a href="/pages/1-1.html">胰臟腫瘤</a></li>
              
                <li><a href="/pages/1-2.html">慢性胰臟炎</a></li>
              
                <li><a href="/pages/1-3.html">胰臟疾病（Pancreas）-急性胰臟炎</a></li>
              
                <li><a href="/pages/1-4.html">PSC vs PBC</a></li>
              
                <li><a href="/pages/1-5.html">Cholangiocarcinoma</a></li>
              
                <li><a href="/pages/1-6.html">Cholangitis</a></li>
              
                <li><a href="/pages/1-7.html">Gallstone ileus</a></li>
              
                <li><a href="/pages/1-8.html">Cholecystitis</a></li>
              
                <li><a href="/pages/1-9.html">Cholelithiasis</a></li>
              
                <li><a href="/pages/1-10.html">膽道感染與腫瘤</a></li>
              
                <li><a href="/pages/1-11.html">膽道阻塞</a></li>
              
                <li><a href="/pages/1-12.html">膽道疾病-膽結石與膽囊炎</a></li>
              
                <li><a href="/pages/1-13.html">肝臟移植與TIPS</a></li>
              
                <li><a href="/pages/1-14.html">肝腫瘤與癌症</a></li>
              
                <li><a href="/pages/1-15.html">代謝性肝病</a></li>
              
                <li><a href="/pages/1-16.html">肝硬化與併發症</a></li>
              
                <li><a href="/pages/1-17.html">脂肪肝與酒精性肝病</a></li>
              
                <li><a href="/pages/1-18.html">急性與慢性肝炎</a></li>
              
                <li><a href="/pages/1-19.html">黃疸與膽紅素異常</a></li>
              
                <li><a href="/pages/1-20.html">肝臟疾病-肝功能異常與評估</a></li>
              
                <li><a href="/pages/1-21.html">Hemorrhoid </a></li>
              
                <li><a href="/pages/1-22.html">直腸肛門疾病</a></li>
              
                <li><a href="/pages/1-23.html">Colorectal Cancer</a></li>
              
                <li><a href="/pages/1-24.html">Ischemic Colitis</a></li>
              
                <li><a href="/pages/1-25.html">Diverticulitis</a></li>
              
                <li><a href="/pages/1-26.html">結腸疾病</a></li>
              
                <li><a href="/pages/1-27.html">腸躁症 IBS</a></li>
              
                <li><a href="/pages/1-28.html">Ulcerative Colitis</a></li>
              
                <li><a href="/pages/1-29.html">Crohn’s Disease</a></li>
              
                <li><a href="/pages/1-30.html">大腸與直腸疾病-IBD</a></li>
              
                <li><a href="/pages/1-31.html">Appendicitis</a></li>
              
                <li><a href="/pages/1-32.html">Peritonitis</a></li>
              
                <li><a href="/pages/1-33.html">急性腹症</a></li>
              
                <li><a href="/pages/1-34.html">小腸阻塞與功能障礙</a></li>
              
                <li><a href="/pages/1-35.html">小腸腫瘤與症候群</a></li>
              
                <li><a href="/pages/1-36.html">Celiac Disease</a></li>
              
                <li><a href="/pages/1-37.html">Acute/Chronic Diarrhea</a></li>
              
                <li><a href="/pages/1-38.html">小腸疾病-腹瀉與吸收障礙</a></li>
              
                <li><a href="/pages/1-39.html">上消化道-上消化道出血</a></li>
              
                <li><a href="/pages/1-40.html">上消化道-胃部疾病</a></li>
              
                <li><a href="/pages/1-41.html">上消化道-吞嚥困難與食道疾病</a></li>
              
                <li><a href="/pages/1-42.html">Esophageal Varices</a></li>
              
                <li><a href="/pages/1-43.html">UGI bleeding </a></li>
              
                <li><a href="/pages/1-44.html">Gastric Cancer</a></li>
              
                <li><a href="/pages/1-45.html">Zollinger-Ellison Syndrome</a></li>
              
                <li><a href="/pages/1-46.html">Gastritis</a></li>
              
                <li><a href="/pages/1-47.html">Peptic Ulcer Disease</a></li>
              
                <li><a href="/pages/1-48.html">Diverticula</a></li>
              
                <li><a href="/pages/1-49.html">Esophageal Rings</a></li>
              
                <li><a href="/pages/1-50.html">Plummer-Vinson Syndrome</a></li>
              
                <li><a href="/pages/1-51.html">食道癌</a></li>
              
                <li><a href="/pages/1-52.html">Achalasia</a></li>
              
                <li><a href="/pages/1-53.html">GERD </a></li>
              
                <li><a href="/pages/1-54.html">Dysphagia 吞嚥困難</a></li>
              
                <li><a href="/pages/1-55.html">GI</a></li>
              
                <li><a href="/pages/1-56.html">ACLS 需要圖片喔</a></li>
              
                <li><a href="/pages/1-57.html">呼吸器</a></li>
              
                <li><a href="/pages/1-58.html">肺癌</a></li>
              
                <li><a href="/pages/1-59.html">EKG</a></li>
              
                <li><a href="/pages/1-60.html">心衰竭</a></li>
              
                <li><a href="/pages/1-61.html">高血脂</a></li>
              
                <li><a href="/pages/1-62.html">Syncope （內容太少了喔）</a></li>
              
                <li><a href="/pages/1-63.html">Cardiomyopathy</a></li>
              
                <li><a href="/pages/1-64.html">瓣膜性心臟病</a></li>
              
                <li><a href="/pages/1-65.html">心律不整</a></li>
              
                <li><a href="/pages/1-66.html">心臟電生理</a></li>
              
                <li><a href="/pages/1-67.html">CV-整體修改建議如下</a></li>
              
                <li><a href="/pages/1-68.html">Peripheral Artery Disease (PAD)</a></li>
              
                <li><a href="/pages/1-69.html">心包疾病 Pericarditis disease</a></li>
              
                <li><a href="/pages/1-70.html">Ischemic heart disease（IHD）</a></li>
              
                <li><a href="/pages/1-71.html">✅模板試作(HTN)</a></li>
              
                <li><a href="/pages/1-72.html">APACHE</a></li>
              
                <li><a href="/pages/1-73.html">SOFA</a></li>
              
                <li><a href="/pages/1-74.html">Lung abscess</a></li>
              
                <li><a href="/pages/1-75.html">Pneumonia</a></li>
              
                <li><a href="/pages/1-76.html">胸腔基礎</a></li>
              
                <li><a href="/pages/1-77.html">Respiratory failure</a></li>
              
                <li><a href="/pages/1-78.html">Pleural effusion</a></li>
              
                <li><a href="/pages/1-79.html">Sleep apnea </a></li>
              
                <li><a href="/pages/1-80.html">Pulmonary embolism</a></li>
              
                <li><a href="/pages/1-81.html">Acute Respiratory Distress Syndrome (ARDS)</a></li>
              
                <li><a href="/pages/1-82.html">執業和環境造成 </a></li>
              
                <li><a href="/pages/1-83.html">Critical care</a></li>
              
                <li><a href="/pages/1-84.html">Hypersensitivity pneumonitis </a></li>
              
                <li><a href="/pages/1-85.html">Interstitial lung disease</a></li>
              
                <li><a href="/pages/1-86.html">Cystic fibrosis</a></li>
              
                <li><a href="/pages/1-87.html">Bronchiectasis </a></li>
              
                <li><a href="/pages/1-88.html">COPD</a></li>
              
                <li><a href="/pages/1-89.html">TRALI</a></li>
              
                <li><a href="/pages/1-90.html">氣喘</a></li>
              
                <li><a href="/pages/1-91.html">DM foot</a></li>
              
                <li><a href="/pages/1-92.html">META</a></li>
              
                <li><a href="/pages/1-93.html">編輯格式</a></li>
              
                <li><a href="/pages/1-94.html">限制性肺疾病</a></li>
              
                <li><a href="/pages/1-95.html">主動脈剝離</a></li>
              
                <li><a href="/pages/1-96.html">Aneurysm</a></li>
              
                <li><a href="/pages/1-97.html">Acute coronary syndrome</a></li>
              
                <li><a href="/pages/1-98.html">肋膜疾病 </a></li>
              
                <li><a href="/pages/1-99.html">Respiratory failure</a></li>
              
                <li><a href="/pages/1-100.html">胸內</a></li>
              
                <li><a href="/pages/1-101.html">Cardiac neoplasm</a></li>
              
                <li><a href="/pages/1-102.html">發燒</a></li>
              
                <li><a href="/pages/1-103.html">休克</a></li>
              
                <li><a href="/pages/1-104.html">內科值班常見情形</a></li>
              
                <li><a href="/pages/1-105.html">Vascular disease</a></li>
              
                <li><a href="/pages/1-106.html">靜脈血栓栓塞症（Venous Thromboembolism, VTE）</a></li>
              
                <li><a href="/pages/1-107.html">Aortic disease</a></li>
              
                <li><a href="/pages/1-108.html">圖庫資源</a></li>
              
                <li><a href="/pages/1-109.html">高血壓</a></li>
              
                <li><a href="/pages/1-110.html">Coronary artery disease</a></li>
              
                <li><a href="/pages/1-111.html">感染</a></li>
              
                <li><a href="/pages/1-112.html">TB</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>其他科</h3>
            <ul>
              
                <li><a href="/pages/2-0.html">乾癬</a></li>
              
                <li><a href="/pages/2-1.html">皮膚炎/濕疹和炎症性疾病</a></li>
              
                <li><a href="/pages/2-2.html">藥物疹</a></li>
              
                <li><a href="/pages/2-3.html">AI prompt</a></li>
              
                <li><a href="/pages/2-4.html">大綱架構</a></li>
              
                <li><a href="/pages/2-5.html">結膜</a></li>
              
                <li><a href="/pages/2-6.html">皮膚腫瘤/皮膚增生</a></li>
              
                <li><a href="/pages/2-7.html">眼瞼</a></li>
              
                <li><a href="/pages/2-8.html">水泡疾病</a></li>
              
                <li><a href="/pages/2-9.html">淚液系統</a></li>
              
                <li><a href="/pages/2-10.html">眼科</a></li>
              
                <li><a href="/pages/2-11.html">圖庫資源</a></li>
              
                <li><a href="/pages/2-12.html">先天性疾病</a></li>
              
                <li><a href="/pages/2-13.html">感染性皮膚病</a></li>
              
                <li><a href="/pages/2-14.html">皮膚科</a></li>
              
                <li><a href="/pages/2-15.html">皮膚色素病</a></li>
              
                <li><a href="/pages/2-16.html"></a></li>
              
                <li><a href="/pages/2-17.html">自體免疫性疾病</a></li>
              
                <li><a href="/pages/2-18.html">ENT</a></li>
              
                <li><a href="/pages/2-19.html">麻醉</a></li>
              
                <li><a href="/pages/2-20.html">復健科</a></li>
              
                <li><a href="/pages/2-21.html">NEURO</a></li>
              
                <li><a href="/pages/2-22.html">精神科</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>外科</h3>
            <ul>
              
                <li><a href="/pages/3-0.html">深層靜脈栓塞（Deep vein thrombosis, DVT）</a></li>
              
                <li><a href="/pages/3-1.html">上肢深層靜脈栓塞（Upper Extremity Deep Vein Thrombosis, UEDVT）</a></li>
              
                <li><a href="/pages/3-2.html">肺栓塞（Pulmonary Embolism）</a></li>
              
                <li><a href="/pages/3-3.html">二尖瓣狹窄（Mitral Valve Stenosis） </a></li>
              
                <li><a href="/pages/3-4.html">周邊動脈阻塞性疾病(Peripheral artery occlusion disease, PAOD) </a></li>
              
                <li><a href="/pages/3-5.html">感染性心內膜炎（Infective endocarditis）</a></li>
              
                <li><a href="/pages/3-6.html">人造瓣膜的選擇(Prosthetic valve) </a></li>
              
                <li><a href="/pages/3-7.html">主動脈逆流（Aortic Regurgitation, AR) </a></li>
              
                <li><a href="/pages/3-8.html">主動脈瓣狹窄（Aortic Stenosis) </a></li>
              
                <li><a href="/pages/3-9.html">二尖瓣閉鎖不全（Mitral Regurgitation）</a></li>
              
                <li><a href="/pages/3-10.html">開放性動脈導管（Patent Ductus Arteriosus, PDA）</a></li>
              
                <li><a href="/pages/3-11.html">部份肺靜脈回流異常（Partial anomalous pulmonary venous return, PAPVR）</a></li>
              
                <li><a href="/pages/3-12.html">肺動脈狹窄（Pulmonary Stenosis）</a></li>
              
                <li><a href="/pages/3-13.html">三心房（cor triatriatum）</a></li>
              
                <li><a href="/pages/3-14.html">右心室雙出口（Double-Outlet Right Ventricle, DORV）</a></li>
              
                <li><a href="/pages/3-15.html">主動脈弓狹窄（CoA）</a></li>
              
                <li><a href="/pages/3-16.html">主動脈弓中斷（Interrupted Aortic Arch, IAA）</a></li>
              
                <li><a href="/pages/3-17.html">心室中膈缺損（Ventricular Septal Defect）</a></li>
              
                <li><a href="/pages/3-18.html">心房中膈缺損（Atrial Septal Defect）</a></li>
              
                <li><a href="/pages/3-19.html">兩側右心房 </a></li>
              
                <li><a href="/pages/3-20.html">肺動脈閉鎖 Pulmonary Valve Atresia</a></li>
              
                <li><a href="/pages/3-21.html">Ebstein anomaly</a></li>
              
                <li><a href="/pages/3-22.html">三尖瓣閉鎖 Tricuspid Valve Atresia</a></li>
              
                <li><a href="/pages/3-23.html">動脈幹 Persistent Truncus Arteriosus</a></li>
              
                <li><a href="/pages/3-24.html">全肺靜脈回流異常（Total anomalous pulmonary venous return, TAPVR）</a></li>
              
                <li><a href="/pages/3-25.html">頭部創傷/顱內出血</a></li>
              
                <li><a href="/pages/3-26.html">Eisenmenger’s Syndrome</a></li>
              
                <li><a href="/pages/3-27.html">神外術後電解質常見失衡</a></li>
              
                <li><a href="/pages/3-28.html">顱內壓</a></li>
              
                <li><a href="/pages/3-29.html">發紺型先天心臟病</a></li>
              
                <li><a href="/pages/3-30.html">左心發育不全 Hypoplastic Left Heart Syndrome </a></li>
              
                <li><a href="/pages/3-31.html">手掌腳掌dermis很厚，可以試著做secondary healing</a></li>
              
                <li><a href="/pages/3-32.html">法洛氏四重症（Tetralogy of Fallot）</a></li>
              
                <li><a href="/pages/3-33.html">大動脈轉位 Transposition of the great arteries, TGA</a></li>
              
                <li><a href="/pages/3-34.html">(V) 冠狀動脈繞道術（Coronary artery bypass graft, CABG）</a></li>
              
                <li><a href="/pages/3-35.html">(V) 主動脈剝離 Aortic Dissection</a></li>
              
                <li><a href="/pages/3-36.html">(V) 動脈瘤 </a></li>
              
                <li><a href="/pages/3-37.html">(X) Transmyocardial laser revascularization(TMLR) </a></li>
              
                <li><a href="/pages/3-38.html">心臟移植</a></li>
              
                <li><a href="/pages/3-39.html">心臟腫瘤</a></li>
              
                <li><a href="/pages/3-40.html">機械式循環輔助(Mechanical Circulatory Support, MCS) </a></li>
              
                <li><a href="/pages/3-41.html">CO2栓塞 </a></li>
              
                <li><a href="/pages/3-42.html">慢性靜脈疾病 </a></li>
              
                <li><a href="/pages/3-43.html">周邊血管疾病</a></li>
              
                <li><a href="/pages/3-44.html">心臟瓣膜疾病</a></li>
              
                <li><a href="/pages/3-45.html">非發紺型先天性心臟病 </a></li>
              
                <li><a href="/pages/3-46.html">先天性心臟病</a></li>
              
                <li><a href="/pages/3-47.html">腦死判定</a></li>
              
                <li><a href="/pages/3-48.html">昏迷指數</a></li>
              
                <li><a href="/pages/3-49.html">NS</a></li>
              
                <li><a href="/pages/3-50.html">顱頸交界處異常(Craniocervical junction anomalies)=Chiari malformation</a></li>
              
                <li><a href="/pages/3-51.html">三叉神經痛</a></li>
              
                <li><a href="/pages/3-52.html">腦瘤</a></li>
              
                <li><a href="/pages/3-53.html">Spinal cord injury[復健]</a></li>
              
                <li><a href="/pages/3-54.html">脊椎疾病</a></li>
              
                <li><a href="/pages/3-55.html">血管畸形</a></li>
              
                <li><a href="/pages/3-56.html">顱內出血</a></li>
              
                <li><a href="/pages/3-57.html">冠狀動脈疾病及冠狀動脈繞道手術</a></li>
              
                <li><a href="/pages/3-58.html">CVS</a></li>
              
                <li><a href="/pages/3-59.html">Acute adomen</a></li>
              
                <li><a href="/pages/3-60.html">GS</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>婦產科</h3>
            <ul>
              
                <li><a href="/pages/4-0.html">男性不孕</a></li>
              
                <li><a href="/pages/4-1.html">胚胎學</a></li>
              
                <li><a href="/pages/4-2.html">子宮肌瘤</a></li>
              
                <li><a href="/pages/4-3.html">陰道鏡</a></li>
              
                <li><a href="/pages/4-4.html">不孕症概論</a></li>
              
                <li><a href="/pages/4-5.html">子宮內膜增生</a></li>
              
                <li><a href="/pages/4-6.html">圖庫資源</a></li>
              
                <li><a href="/pages/4-7.html">子宮鏡</a></li>
              
                <li><a href="/pages/4-8.html">陰道癌</a></li>
              
                <li><a href="/pages/4-9.html">外陰癌</a></li>
              
                <li><a href="/pages/4-10.html">子宮內膜癌</a></li>
              
                <li><a href="/pages/4-11.html">腹腔鏡</a></li>
              
                <li><a href="/pages/4-12.html">OP</a></li>
              
                <li><a href="/pages/4-13.html">泌尿道感染</a></li>
              
                <li><a href="/pages/4-14.html">骨盆腔器官脱垂</a></li>
              
                <li><a href="/pages/4-15.html">尿失禁</a></li>
              
                <li><a href="/pages/4-16.html">排尿生理學與尿路動力學檢查</a></li>
              
                <li><a href="/pages/4-17.html">URO</a></li>
              
                <li><a href="/pages/4-18.html">子宮腔沾黏</a></li>
              
                <li><a href="/pages/4-19.html">卵巢過度刺激症候群</a></li>
              
                <li><a href="/pages/4-20.html">女性不孕</a></li>
              
                <li><a href="/pages/4-21.html">人工協助生殖技術</a></li>
              
                <li><a href="/pages/4-22.html">不孕症</a></li>
              
                <li><a href="/pages/4-23.html">反覆性流產</a></li>
              
                <li><a href="/pages/4-24.html">骨質疏鬆症</a></li>
              
                <li><a href="/pages/4-25.html">更年期及荷爾蒙治療</a></li>
              
                <li><a href="/pages/4-26.html">多囊性卵巢症候群</a></li>
              
                <li><a href="/pages/4-27.html">原發性卵巢功能不全</a></li>
              
                <li><a href="/pages/4-28.html">無月經</a></li>
              
                <li><a href="/pages/4-29.html">青春期</a></li>
              
                <li><a href="/pages/4-30.html">月經週期</a></li>
              
                <li><a href="/pages/4-31.html">女性內分泌學</a></li>
              
                <li><a href="/pages/4-32.html">婦科急症</a></li>
              
                <li><a href="/pages/4-33.html">婦科手術併發症</a></li>
              
                <li><a href="/pages/4-34.html">口服避孕藥</a></li>
              
                <li><a href="/pages/4-35.html">子宮外孕</a></li>
              
                <li><a href="/pages/4-36.html">子宮內膜異位症</a></li>
              
                <li><a href="/pages/4-37.html">婦科感染症</a></li>
              
                <li><a href="/pages/4-38.html">一般婦科學</a></li>
              
                <li><a href="/pages/4-39.html">妊娠滋養層疾病</a></li>
              
                <li><a href="/pages/4-40.html">子宮頸癌</a></li>
              
                <li><a href="/pages/4-41.html">子宮頸癌前病變</a></li>
              
                <li><a href="/pages/4-42.html">人類乳突病毒與子宮頸疫苗</a></li>
              
                <li><a href="/pages/4-43.html">卵巢性索間質腫瘤</a></li>
              
                <li><a href="/pages/4-44.html">卵巢生殖細胞腫瘤</a></li>
              
                <li><a href="/pages/4-45.html">卵巢上皮細胞腫瘤</a></li>
              
                <li><a href="/pages/4-46.html">卵巢囊腫或腫瘤概論</a></li>
              
                <li><a href="/pages/4-47.html">婦科良性與惡性腫瘤</a></li>
              
                <li><a href="/pages/4-48.html">解剖學</a></li>
              
                <li><a href="/pages/4-49.html">懷孕併甲狀腺疾病</a></li>
              
                <li><a href="/pages/4-50.html">妊娠糖尿病</a></li>
              
                <li><a href="/pages/4-51.html">妊娠高血壓與子癲前症</a></li>
              
                <li><a href="/pages/4-52.html">產褥期</a></li>
              
                <li><a href="/pages/4-53.html">新生兒</a></li>
              
                <li><a href="/pages/4-54.html">產後出血</a></li>
              
                <li><a href="/pages/4-55.html">過期妊娠與催生</a></li>
              
                <li><a href="/pages/4-56.html">流產與終止妊娠</a></li>
              
                <li><a href="/pages/4-57.html">生產胎兒監視</a></li>
              
                <li><a href="/pages/4-58.html">肩難產</a></li>
              
                <li><a href="/pages/4-59.html">正常分娩與產程遲滯</a></li>
              
                <li><a href="/pages/4-60.html">生產評估</a></li>
              
                <li><a href="/pages/4-61.html">安胎</a></li>
              
                <li><a href="/pages/4-62.html">早產、早期陣痛與早期破水</a></li>
              
                <li><a href="/pages/4-63.html">產前出血</a></li>
              
                <li><a href="/pages/4-64.html">產前胎兒評估</a></li>
              
                <li><a href="/pages/4-65.html">胎兒健康</a></li>
              
                <li><a href="/pages/4-66.html">產檢</a></li>
              
                <li><a href="/pages/4-67.html">產婦胎兒生理學</a></li>
              
                <li><a href="/pages/4-68.html">胚胎解剖學</a></li>
              
                <li><a href="/pages/4-69.html">高危險妊娠</a></li>
              
                <li><a href="/pages/4-70.html">產後時期</a></li>
              
                <li><a href="/pages/4-71.html">生產時期</a></li>
              
                <li><a href="/pages/4-72.html">產前時期</a></li>
              
                <li><a href="/pages/4-73.html">OB</a></li>
              
                <li><a href="/pages/4-74.html">GYN</a></li>
              
            </ul>
          </li>
        
          <li>
            <h3>籌備行政事項</h3>
            <ul>
              
                <li><a href="/pages/5-0.html">工程組測試頁面</a></li>
              
                <li><a href="/pages/5-1.html">婦產科</a></li>
              
                <li><a href="/pages/5-2.html">示範ITP</a></li>
              
                <li><a href="/pages/5-3.html">外科</a></li>
              
                <li><a href="/pages/5-4.html">✅模板試作(HTN)</a></li>
              
                <li><a href="/pages/5-5.html">FC架構參考</a></li>
              
                <li><a href="/pages/5-6.html">內科</a></li>
              
                <li><a href="/pages/5-7.html">兒科</a></li>
              
            </ul>
          </li>
        
      </ul>
    </div>
    <div class="twelve wide column">
      <div class="ui segment">
        <div id="pageContent"><html lang="en-US"><head>
		<title>Acute coronary syndrome</title>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
		<meta name="created" content="2025-02-26T17:29:00.0000000">
	</head>
	<body data-absolute-enabled="true" style="font-family:Calibri;font-size:11pt">
		<div style="position:absolute;left:48px;top:115px;width:576px">
			<ul>
				<li><p lang="zh-TW" style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei Light;font-size:16pt">編輯格式</span></p>
				<ul>
					<li style="list-style-type:circle"><p lang="zh-TW" style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei Light;font-size:16pt">顏色註記方式</span></p>
					<ul>
						<li><span lang="zh-TW"><span style="font-family:Microsoft JhengHei Light">重要標</span><span style="font-family:Microsoft JhengHei Light;color:black">題</span><span lang="en-US" style="font-family:Microsoft JhengHei Light"> : </span><span style="font-family:Microsoft JhengHei Light;color:#1e4e79">母標題藍色</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#1e4e79">(</span><span style="font-family:Microsoft JhengHei Light;color:#1e4e79">最暗</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#1e4e79">)</span><span style="font-family:Microsoft JhengHei Light;color:#1e4e79">標記</span><span lang="en-US" style="font-family:Microsoft JhengHei Light">/</span><span style="font-family:Microsoft JhengHei Light;color:#2e75b5">子標題藍色</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#2e75b5">(</span><span style="font-family:Microsoft JhengHei Light;color:#2e75b5">較暗</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#2e75b5">,25%)</span><span style="font-family:Microsoft JhengHei Light;color:#2e75b5">標記</span></span></li>
						<li><span lang="zh-TW"><span style="font-family:Microsoft JhengHei Light">重要術式治療藥物</span><span lang="en-US" style="font-family:Microsoft JhengHei Light"> : </span><span style="font-family:Microsoft JhengHei Light;color:#70ad47;font-weight:bold">綠色標記</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#70ad47;font-weight:bold">+</span><span style="font-family:Microsoft JhengHei Light;color:#70ad47;font-weight:bold">粗體</span></span></li>
						<li><span lang="zh-TW"><span style="font-family:Microsoft JhengHei Light">重要內文</span><span lang="en-US" style="font-family:Microsoft JhengHei Light"> : </span><span style="font-family:Microsoft JhengHei Light;color:#c00000">紅色</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#c00000">(</span><span style="font-family:Microsoft JhengHei Light;color:#c00000">標準色彩</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#c00000">)</span><span lang="en-US" style="font-family:Microsoft JhengHei Light">/</span><span style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">橘色</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">+</span><span style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">粗體</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">(</span><span style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">橘色那一欄第一個</span><span lang="en-US" style="font-family:Microsoft JhengHei Light;color:#ed7d31;font-weight:bold">)</span><span lang="en-US" style="font-family:Microsoft JhengHei Light">(</span><span style="font-family:Microsoft JhengHei Light">如果同色太醜就紅橘相間</span><span lang="en-US" style="font-family:Microsoft JhengHei Light">)</span></span></li>
						<li><span lang="zh-TW"><span style="font-family:Microsoft JhengHei Light">直接來複製顏色格式一定不會錯</span><span lang="en-US" style="font-family:Microsoft JhengHei Light">xd</span></span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei Light;font-size:16pt;color:black">流行病學（Epidemiology）</span></h3>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">台灣急性冠狀症候群ACS 現況</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei Light;color:black">ACS 是台灣主要的心血管疾病之一，發病率隨年齡增加</span></li>
						<li><span style="font-family:Microsoft JhengHei Light;color:black">STEMI 與 NSTEMI 皆可導致</span><span style="font-family:Microsoft JhengHei Light;color:black">心衰竭、心律不整、猝死</span></li>
						<li><span style="font-family:Microsoft JhengHei Light;color:black">近年來，</span><span style="font-family:Microsoft JhengHei Light;color:black">高齡、糖尿病、腎功能不全患者比例增加</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">急性冠症候群（Acute Coronary Syndromes, ACS）</span></h3>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">急性冠症候群主要由</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">動脈粥樣硬化斑塊破裂</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">（Plaque Rupture），</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">導致血栓形成（Thrombus Formation）引起</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，依據血管阻塞程度可分為以下類型：</span></li>
				</ul>
				</li>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">ACS分類</span></h3>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">類型</span></td>
						<td style="border:1px solid;text-align:center"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">血管阻塞程度</span></span></td>
						<td style="border:1px solid;text-align:center"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">ECG 變化</span></span></td>
						<td style="border:1px solid;text-align:center"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">心肌酵素（Troponin）</span></span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">不穩定型心絞痛（Unstable Angina, UA）</span></span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">部分阻塞（不完全阻塞）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">可能有ST段壓低或T 波倒置</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">正常</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">非ST段抬高型心肌梗塞（NSTEMI）</span></span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">部分阻塞（不完全阻塞）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ST段壓低或T波改變</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">上升</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">ST段抬高型心肌梗塞（STEMI）</span></span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">完全阻塞（100%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ST段抬高</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">上升</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><p lang="zh-TW" style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">不穩定型心絞痛</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">（Unstable Angina, UA）</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">機轉</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">斑塊破裂 </span><span style="font-family:Segoe UI Symbol;color:black">➝</span><span style="font-family:Microsoft JhengHei;color:black"> </span><span style="font-family:Microsoft JhengHei;color:#c00000">部分血栓形成</span><span style="font-family:Microsoft JhengHei;color:black">（但未完全阻塞）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">心肌未壞死</span><span style="font-family:Microsoft JhengHei;color:black">（沒有心肌酵素上升）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">臨床表現</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">休息時胸痛（新發或惡化）</span><span style="font-family:Microsoft JhengHei;color:black">，可能持續 &gt;10分鐘，&lt; 30分鐘</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">與</span><span style="font-family:Microsoft JhengHei;color:black">穩定型心絞痛（Stable Angina）不同</span><span style="font-family:Microsoft JhengHei;color:black">，休息時仍可能發作</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ECG 可能</span><span style="font-family:Microsoft JhengHei;color:black">正常</span><span style="font-family:Microsoft JhengHei;color:black">或出現 </span><span style="font-family:Microsoft JhengHei;color:black">ST 段壓低 / T 波倒置</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">診斷關鍵</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">無心肌酵素上升</span><span style="font-family:Microsoft JhengHei;color:black">（Troponin、CK-MB 正常）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ECG 可能有 </span><span style="font-family:Microsoft JhengHei;color:black">ST 段壓低 / T 波倒置</span><span style="font-family:Microsoft JhengHei;color:black">，但 </span><span style="font-family:Microsoft JhengHei;color:black">無 ST 段抬高</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">GRACE/TIMI score 風險評估</span><span style="font-family:Microsoft JhengHei;color:black">決定是否早期介入</span><span lang="zh-TW" style="font-family:Microsoft JhengHei">￼</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">非ST段抬高型心肌梗塞</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">（NSTEMI）</span></h3>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black"> </span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">機轉</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">部分血栓阻塞</span><span style="font-family:Microsoft JhengHei;color:black">（導致部分心肌缺血壞死）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">影響</span><span style="font-family:Microsoft JhengHei;color:black">內膜層心肌（Subendocardial Infarction）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">心肌酵素上升</span><span style="font-family:Microsoft JhengHei;color:black">（Troponin↑）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">臨床表現</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">持續性胸痛 &gt; 10分鐘，&lt; 30分鐘</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">可能伴隨呼吸困難、盜汗、噁心</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ECG可能有</span><span style="font-family:Microsoft JhengHei;color:black">ST段壓低 / T波倒置</span><span style="font-family:Microsoft JhengHei;color:black">，但</span><span style="font-family:Microsoft JhengHei;color:black">無ST段抬高</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">診斷關鍵</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">心肌酵素上升</span><span style="font-family:Microsoft JhengHei;color:black">（Troponin、CK-MB ↑）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">ECG：ST段壓低 / T波倒置</span><span style="font-family:Microsoft JhengHei;color:black">（但無 ST段抬高）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">GRACE/TIMI score 風險評估</span><span style="font-family:Microsoft JhengHei;color:black">決定是否早期介入</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><p lang="zh-TW" style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">TIMI Score</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">預測</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">14天內心血管事件（死亡、MI、需緊急血運重建）的風險</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，滿分7分，分數越高，風險越高！</span></li>
				</ul>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">危險因子</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">評分（每項 +1 分）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">年齡 ≥ 65 歲</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">≥ 3 個冠心病危險因子</span><span style="font-family:Microsoft JhengHei;color:black">（高血壓、糖尿病、吸菸、高膽固醇、早發冠心病家族史）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">已知冠狀動脈疾病（CAD，冠狀動脈狹窄 &gt; 50%）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">過去 24 小時內出現嚴重心絞痛（Angina）≥ 2 次</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">使用抗血小板藥物（Aspirin）但仍有症狀</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">心電圖（ECG）表現 ST 段壓低 ≥ 0.5mm</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">初始心肌酵素（Troponin 或 CK-MB）升高</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">+1</span></td>
					</tr>
				</tbody></table>
			</ul>
			<br>
			<h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei Light;font-size:16pt;color:black">流行病學（Epidemiology）</span></h3>
			<br>
			<h3 style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">急性冠症候群（Acute Coronary Syndromes, ACS）</span></h3>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">ACS分類</span></h3>
			<br>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">非ST段抬高型心肌梗塞</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">（NSTEMI）</span></h3>
			<br>
			<br>
			<ul>
				<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">TIMI Score 風險分層</span></li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">TIMI 分數</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">14 天內心血管事件風險</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">0-1 分</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">低風險（4-5%）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">2 分</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中低風險（8%）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">3 分</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中等風險（13%）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">4 分</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">中高風險（20%）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">5-7 分</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高風險（26-41%）</span></td>
					</tr>
				</tbody></table>
				<p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:#c00000">TIMI Score </span><span style="font-family:Cambria Math;color:#c00000">≥</span><span style="font-family:Microsoft JhengHei;color:#c00000"> 3 → 建議做侵入性治療（PCI）</span></p>
				<br>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">GRACE score</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">在NSTEMI及UA的風險評估上，GRACE Score 和 TIMI Score都可用於臨床決策，但台灣與國際guideline（TSOC、AHA、ESC）</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">較推薦使用 GRACE Score</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">來</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">評估預後風險與是否需要早期介入治療</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">。</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">主要用於評估</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">急性冠症候群（ACS）患者的院內及出院後6個月內死亡風險</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，特別適用於</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">NSTEMI與不穩定型心絞痛（UA）</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">GRACE Score根據以下</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">8個臨床指標</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">計算分數</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:#1a1a1a">，</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:#1a1a1a">計分法複雜，可上網算：</span></li>
					<table style="border:1px solid;border-collapse:collapse">
						<tbody><tr>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">變項</span></td>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">內容</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">年齡</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">年齡越大，風險越高</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">心率（Heart rate）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">心率越高，風險越高</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">收縮壓（SBP, mmHg）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">血壓越低，風險越高</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">Killip 分級</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">依據心臟衰竭嚴重度評估</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">心搏停止（Cardiac arrest）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">是否有院外心搏停止</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">血清肌酐（Serum Creatinine, mg/dL）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">腎功能不佳者風險較高</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">ST 段變化（ST-segment deviation）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">ST 段改變者風險較高</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">心肌標誌物（Cardiac biomarkers）</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">Troponin 或 CK-MB 陽性者風險較高</span></td>
						</tr>
					</tbody></table>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">GRACE Score 依照總分</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">預測院內及6個月內死亡風險</span><span style="font-family:Microsoft JhengHei Light;font-size:14pt;color:black">，並用於決定是否進行侵入性治療。</span></li>
					<table style="border:1px solid;border-collapse:collapse">
						<tbody><tr>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">GRACE 總分</span></td>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">死亡風險</span></td>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">風險等級</span></td>
							<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei Light;color:black">建議處置</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">≤108</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">低風險</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">院內死亡率 &lt;1%</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">可考慮藥物保守治療</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">109–140</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">中風險</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">院內死亡率 1-3%</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">建議 24–72 小時內侵入性策略（PCI）</span></td>
						</tr>
						<tr>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">&gt;140</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">高風險</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">院內死亡率 &gt;3%</span></td>
							<td style="border:1px solid"><span style="font-family:Microsoft JhengHei Light;color:black">緊急侵入性策略（PCI within 2h）</span></td>
						</tr>
					</tbody></table>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">不穩定型心絞痛及NSTEMI治療</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">主要治療目標：穩定病況、減少再梗塞</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">UA/NSTEMI：冠狀動脈「不完全阻塞」，仍有部分血流供應心肌，因此</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">不需要緊急血栓溶解（Thrombolysis）。</span></li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">初</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">期藥物治療（Antithrombotic &amp; Anti-ischemic Therapy）</span></p>
				<ul>
					<li style="list-style-type:circle"><h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗血小板藥物（Antiplatelet Agents）</span></h4>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Aspirin（ASA）</span><span style="font-family:Microsoft JhengHei;color:black">：永久性抑制 COX-1，減少 Thromboxane A2生成，防止血小板聚集</span></li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">P2Y12 受體拮抗劑（Clopidogrel / Prasugrel / Ticagrelor）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">可與 Aspirin 合併使用（</span><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Dual Antiplatelet Therapy, DAPT</span><span style="font-family:Microsoft JhengHei;color:black">）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Ticagrelor 作用最強（但增加出血風險）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Prasugrel 禁用於中風病史患者</span></li>
						</ul>
						</li>
					</ul>
					</li>
					<li style="list-style-type:circle"><h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗凝血藥物（Anticoagulants）</span></h4>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Heparin（UFH 或 LMWH）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">減少新血栓形成，預防進一步阻塞</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">UFH（未分化肝素）</span><span style="font-family:Microsoft JhengHei;color:black"> 需持續監測 </span><span style="font-family:Microsoft JhengHei;color:black">aPTT</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">LMWH（低分子量肝素，如 Enoxaparin）</span><span style="font-family:Microsoft JhengHei;color:black">：較穩定、不需監測 aPTT，臨床更常用</span></li>
						</ul>
						</li>
						<li><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Bivalirudin（直接凝血酶抑制劑）</span><span style="font-family:Microsoft JhengHei;color:black">，如對 Heparin 過敏可考慮</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗缺血藥物（Anti-ischemic Therapy）</span></h4>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Beta-blockers</span><span style="font-family:Microsoft JhengHei;color:black">（β 阻斷劑）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">減少心肌氧氣消耗（降低 HR、BP、心肌收縮力）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">禁忌症</span><span style="font-family:Microsoft JhengHei;color:black">：心因性休克、嚴重支氣管痙攣（如 COPD, Asthma）</span></li>
						</ul>
						</li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Nitrates</span><span style="font-family:Microsoft JhengHei;color:black">（如 Nitroglycerin）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">緩解心絞痛，改善冠狀動脈血流</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">禁忌症</span><span style="font-family:Microsoft JhengHei;color:black">：嚴重低血壓、右心梗塞（RV infarction）</span></li>
						</ul>
						</li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">Statins</span><span style="font-family:Microsoft JhengHei;color:black">（高劑量，如 Atorvastatin 80mg）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">穩定動脈粥狀斑塊，減少心血管事件</span></li>
							<br>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">介入治療（非緊急性心導管術 /PCI）</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">NSTEMI 不需要緊急PCI</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，但</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">高風險患者仍應該考慮早期介入治療。</span></p>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">適用族群：高危險族群</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">GRACE score高</span><span style="font-family:Microsoft JhengHei;color:black">（預測6個月內死亡風險）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">反覆胸痛 / 血流動力學不穩</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">明顯 ST-T 變化或生物標誌物升高（如 Troponin）</span></li>
						</ul>
						</li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">方法</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">冠狀動脈造影（Coronary Angiography），依狀況決定是否放置支架（PCI）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:#70ad47;font-weight:bold">必要時行冠狀動脈繞道手術（CABG）</span></li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="color:black">風險分層</span></td>
						<td style="border:1px solid;text-align:center"><span style="color:black">治療策略</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="color:black">高風險（GRACE &gt;140）</span></td>
						<td style="border:1px solid"><span style="color:black">緊急 PCI（2 小時內）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="color:black">中風險（GRACE 109-140）</span></td>
						<td style="border:1px solid"><span style="color:black">24-72 小時內 PCI</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="color:black">低風險（GRACE &lt;109）</span></td>
						<td style="border:1px solid"><span style="color:black">藥物治療</span><span style="color:black">（DAPT、抗凝、Statins）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="color:black">藥物治療</span></td>
						<td style="border:1px solid"><span style="color:black">Aspirin + P2Y12 抑制劑 + Heparin（UFH/LMWH）</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">ST段抬高型心肌梗塞（STEMI）</span></h3>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">機轉</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">完全血管阻塞（100%），導致心肌急性缺血</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">影響全層心肌（Transmural Infarction）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">臨床表現</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">劇烈胸痛（可能持續 &gt;30分鐘）</span><span style="font-family:Microsoft JhengHei;color:black">，可能放射至左臂、下顎、頸部</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">可能伴有呼吸困難、盜汗、嘔吐</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">無法被休息或舌下含服 NTG 緩解</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ECG：</span><span style="font-family:Microsoft JhengHei;color:#c00000">ST 段elevation</span><span style="font-family:Microsoft JhengHei;color:black">，可能合併新發左束支傳導阻滯（LBBB）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">診斷關鍵</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">心肌酵素明顯上升</span><span style="font-family:Microsoft JhengHei;color:black">（Troponin I/T、CK-MB ↑）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ECG：ST 段抬高</span><span style="font-family:Microsoft JhengHei;color:black">≥1 mm（連續兩個肢體導聯）或 ≥2 mm（連續胸導聯）</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">STEMI ECG變化：</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#c00000">至少2個連續導程ST段抬高</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，定義如下：</span></p>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">V2-V3</span><span style="font-family:Microsoft JhengHei;color:black">：</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">男性 &lt;40 歲：≥2.5 mm</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">男性 ≥40 歲：≥2.0 mm</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">女性：≥1.5 mm</span></li>
						</ul>
						</li>
						<li><span style="font-family:Microsoft JhengHei;color:black">其他導程：≥1 mm</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">新發左束支傳導阻滯（LBBB）</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">，合併缺血症狀時，亦視為 STEMI</span></li>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">病程發展：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">超急性期</span><span style="font-family:Microsoft JhengHei;color:black">（數分鐘內）：高聳T波（Hyperacute T waves）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">急性期</span><span style="font-family:Microsoft JhengHei;color:black">（數小時內）：ST段抬高（ST elevation）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">數天內</span><span style="font-family:Microsoft JhengHei;color:black">：病理性Q波（Pathologic Q wave）、T 波倒置</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">數週至數月</span><span style="font-family:Microsoft JhengHei;color:black">：ST段恢復基線，T波持續倒置，病理性 Q 波可永久存在</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">如果 </span><span style="font-family:Microsoft JhengHei;color:black">ST段在STEMI發作後2週仍未恢復至基線</span><span style="font-family:Microsoft JhengHei;color:black">，可能暗示</span><span style="font-family:Microsoft JhengHei;color:black">心室瘤（Ventricular Aneurysm）</span><span style="font-family:Microsoft JhengHei;color:black"> 形成。這是一種</span><span style="font-family:Microsoft JhengHei;color:black">慢性併發症</span><span style="font-family:Microsoft JhengHei;color:black">，通常發生於</span><span style="font-family:Microsoft JhengHei;color:black">前壁心肌梗塞（Anterior MI, LAD 供應區域）</span><span style="font-family:Microsoft JhengHei;color:black">，因為該區心肌壞死後變成</span><span style="font-family:Microsoft JhengHei;color:black">纖維化瘢痕（Scar）</span><span style="font-family:Microsoft JhengHei;color:black">，導致局部心室壁失去收縮能力（Akinetic zone），甚至在心臟收縮時呈現反向突出（Dyskinesia）</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">Cardiac biomarker重點：</span></h3>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="width:99;border:1px solid;text-align:center"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:black">生物標記</span></span></td>
						<td style="width:82;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">升高時間</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">高峰時間</span></td>
						<td style="width:82;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">持續時間</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">適用情境</span></td>
					</tr>
					<tr>
						<td style="width:99;border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">Troponin I/T</span></span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">2-4 小時</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">24-48 小時</span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">7-14 天</span></td>
						<td style="border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">最敏感</span><span style="font-family:Microsoft JhengHei;color:black">、特異的 MI 標記，但</span><span style="font-family:Microsoft JhengHei;color:#c00000">不適合偵測再梗塞</span></span></td>
					</tr>
					<tr>
						<td style="width:99;border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">CK-MB</span></span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">4-6 小時</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">24 小時</span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">2-3 天</span></td>
						<td style="border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:black">適合</span><span style="font-family:Microsoft JhengHei;color:#c00000">偵測再梗塞</span></span></td>
					</tr>
					<tr>
						<td style="width:99;border:1px solid"><span lang="zh-TW"><span style="font-family:Microsoft JhengHei;color:#c00000">Myoglobin</span></span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">1-2 小時</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">6-12 小時</span></td>
						<td style="width:82;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">24 小時</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">最快升高，但特異性低</span></td>
					</tr>
				</tbody></table>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">重點整理：</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">目前臨床上主要使用</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Troponin（I或T）</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">來診斷</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">急性心肌梗塞</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">CK-MB 則可輔助偵測</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">再梗塞</span></li>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">Myoglobin</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">特異性低（骨骼肌損傷也會影響）臨床上較少單獨使用</span></li>
				</ul>
				</li>
				<br>
				<li><h2 lang="zh-TW" style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">冠狀動脈解剖</span></h2>
				</li>
				<img alt="File:Coronary vessels, with annotated arteries.svg" width="362.5" height="232.5" src="\assets\images\0-56CE32FBA64785CA!s8b94d9a4e33f42d0bac3dad4d483022c\內科_Acute_coronary_syndrome_0.jpg" data-src-type="image/png" data-fullres-src="https://graph.microsoft.com/v1.0/users('pinnhanniscute@hotmail.com')/onenote/resources/0-70f21283e472410616772c5c3260c941!1-56CE32FBA64785CA!sed1d6b6700574aaba7b06977784f4d68/$value" data-fullres-src-type="image/png">
				<ul>
					<li style="list-style-type:circle"><h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">主要血管分佈</span></h2>
					<ul>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">左心冠狀動脈（Left Coronary Artery, LCA）</span></li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">Left Main（LM）</span><span style="font-family:Microsoft JhengHei;color:black"> → 分出兩條：</span></p>
						<ul>
							<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">LAD（Left Anterior Descending）</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">沿 interventricular plane</span><span style="font-family:Microsoft JhengHei;color:black">（前降支）</span></li>
								<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">分支</span><span style="font-family:Microsoft JhengHei;color:black">：</span></p>
								<ul>
									<li style="list-style-type:square"><span style="font-family:Microsoft JhengHei;color:black">Septal Branch（S）</span><span style="font-family:Microsoft JhengHei;color:black">：供應</span><span style="font-family:Microsoft JhengHei;color:black">心室中隔</span></li>
									<li style="list-style-type:square"><span style="font-family:Microsoft JhengHei;color:black">Diagonal Branch（D）</span><span style="font-family:Microsoft JhengHei;color:black">：供應</span><span style="font-family:Microsoft JhengHei;color:black">左心室前壁</span></li>
								</ul>
								</li>
							</ul>
							</li>
							<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">LCX（Left Circumflex）</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">繞左心側壁</span><span style="font-family:Microsoft JhengHei;color:black">（迴旋支）</span></li>
								<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">分支</span><span style="font-family:Microsoft JhengHei;color:black">：</span></p>
								<ul>
									<li style="list-style-type:square"><span style="font-family:Microsoft JhengHei;color:black">Obtuse Marginal（OM）</span><span style="font-family:Microsoft JhengHei;color:black">：供應</span><span style="font-family:Microsoft JhengHei;color:black">左心室側壁</span></li>
								</ul>
								</li>
							</ul>
							</li>
						</ul>
						</li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">右心冠狀動脈（Right Coronary Artery, RCA）</span></p>
						<ul>
							<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">主要分支</span><span style="font-family:Microsoft JhengHei;color:black">：</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Conus Branch（CB）</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Sinus Node Branch（SN）</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">供應 SA node</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Right Ventricular Branch（RV）</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Acute Marginal（AcM）</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">供應右心室</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Posterolateral（PL）</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">供應左心室後壁</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Posterior Descending（PD）</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">供應左心室下壁、後壁</span></li>
							</ul>
							</li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				<br>
				<li><p lang="zh-TW" style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">STEMI 缺血區域對應 ECG 變化</span></p>
				<ul>
					<li style="list-style-type:circle;margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">ST 段抬高（STE）可用來定位缺血區域，但ST段壓低（STD）無法確定確切缺血位置</span></li>
				</ul>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">缺血區域</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">供應血管</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">ECG 導極變化（STE）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Septum（中隔）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LAD</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">V1、V2</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LV Anterior wall（前壁）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LAD</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">V3、V4</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LV Lateral wall（側壁）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LCX 或 LAD 遠端</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">V5、V6、I、aVL</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LV Inferior wall（下壁）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">RCA（較常見）或 LCX</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">II、III、aVF</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">LV Posterior wall（後壁）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">RCA 或 LCX</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">V1、V2（Tall R or STD）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">RV（右心室）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">RCA 近端</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">V4R（右側導極）</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">下壁STEMI 進一步分析（國考常考）</span></h2>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">下壁 STEMI（II、III、aVF STE）常見於 RCA 阻塞，但 LCX 也可能導致！如何鑑別？</span></p>
					<ul>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">觀察 lead II vs. lead III 的 STE</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">Lead III STE &gt; Lead II</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">RCA 阻塞</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">Lead II STE &gt; Lead III，且側壁（I、aVL）也有 STE</span><span style="font-family:Microsoft JhengHei;color:black"> → </span><span style="font-family:Microsoft JhengHei;color:black">LCX 阻塞</span></li>
						</ul>
						</li>
						<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">右心室受累（RV infarction）</span></p>
						<ul>
							<li><span style="font-family:Microsoft JhengHei;color:black">V4R STE</span><span style="font-family:Microsoft JhengHei;color:black"> → RCA 近端阻塞</span></li>
							<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">臨床意義</span><span style="font-family:Microsoft JhengHei;color:black">：</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">右心梗塞不可使用 Nitrate（NTG）！</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">需補充體液（Hydration）</span><span style="font-family:Microsoft JhengHei;color:black"> 以維持前負荷</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">約 </span><span style="font-family:Microsoft JhengHei;color:black">30% 下壁 STEMI 會合併右心梗塞</span></li>
							</ul>
							</li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">後壁 STEMI（Posterior MI）</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">ECG 變化</span></p>
					<ul>
						<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">V1、V2 Tall R 波</span><span style="font-family:Microsoft JhengHei;color:black">（對應後壁的 Q 波）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">V1、V2 ST 段壓低（STD）</span><span style="font-family:Microsoft JhengHei;color:black">（對應後壁的 STE）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">可合併下壁或側壁 STEMI</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">V7–V9（後側導極）</span><span style="font-family:Microsoft JhengHei;color:black"> STE 可確診</span></li>
					</ul>
					</li>
					<br>
				</ul>
				</li>
				<li><h2 lang="zh-TW" style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">STEMI急性治療（國考考點）</span></h2>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">治療目標：</span><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black"> 立即恢復心肌灌流（Time is muscle!）</span></p>
					<ul>
						<li><p lang="zh-TW" style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:#c00000">Primary PCI（首選！）</span></p>
						<ul>
							<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">目標：</span><span style="font-family:Microsoft JhengHei;color:#c00000">Door-to-Balloon </span><span lang="x-IV" style="font-family:Cambria Math;color:#c00000">≤</span><span style="font-family:Microsoft JhengHei;color:#c00000"> 90 分鐘</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">「Primary」指的是未先給血栓溶解劑，直接進行 PCI</span><span style="font-family:Microsoft JhengHei;color:black">（經皮冠狀動脈介入治療）</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">比血栓溶解劑更能降低死亡率、再梗塞風險</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">若能在 120 分鐘內完成 PCI，優先選擇！</span></li>
							<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">適用對象</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">症狀超過3小時</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">Killip class ≥ III（心衰、休克）</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">有血栓溶解劑的禁忌症</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">高出血風險</span></li>
							</ul>
							</li>
						</ul>
						</li>
						<li><p lang="zh-TW" style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:#c00000">Thrombolytic Therapy（血栓溶解劑）</span></p>
						<ul>
							<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">目標：</span><span style="font-family:Microsoft JhengHei;color:#c00000">Door-to-Needle </span><span lang="x-IV" style="font-family:Cambria Math;color:#c00000">≤</span><span style="font-family:Microsoft JhengHei;color:#c00000"> 30 分鐘</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">適用於 </span><span style="font-family:Microsoft JhengHei;color:black">無法在 120 分鐘內完成 PCI 的醫院</span></li>
							<li><span style="font-family:Microsoft JhengHei;color:black">施打後仍須</span><span style="font-family:Microsoft JhengHei;color:black">立即轉診</span><span style="font-family:Microsoft JhengHei;color:black">至可做 PCI 的醫院</span></li>
							<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">適用對象</span></p>
							<ul>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">症狀發作 &lt; 12 小時，</span><span style="font-family:Microsoft JhengHei;color:black">超過 3小時效果下降</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">無禁忌症</span></li>
								<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">無法在 120 分鐘內完成 PCI</span></li>
							</ul>
							</li>
						</ul>
						</li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">再灌流策略（PCI vs. 溶栓）</span></h3>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">治療</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">適應症</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">時間限制</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">備註</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Primary PCI</span><span style="font-family:Microsoft JhengHei;color:black">（首選）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">具 STEMI 診斷，且可在 </span><span style="font-family:Microsoft JhengHei;color:black">120 分鐘內</span><span style="font-family:Microsoft JhengHei;color:black">完成 PCI</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Door-to-balloon time ≤90 分鐘</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">最佳療法，較少出血風險</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Fibrinolysis（溶栓治療）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">無法在 </span><span style="font-family:Microsoft JhengHei;color:black">120 分鐘內</span><span style="font-family:Microsoft JhengHei;color:black">完成 PCI</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Door-to-needle time ≤30 分鐘</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">適用於無法立即進行 PCI 的情況</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">根據衛福部 STEMI 治療指引</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">與臨床實務，以下是常見的</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">醫院內部處置時間（Door-to-Reperfusion Time）</span><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black"> 目標</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">常見溶栓藥物：</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">tPA（Alteplase）、Reteplase（rPA）、Tenecteplase（TNK-tPA）</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#2e75b5">禁忌症（國考愛考）</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">近期出血性中風</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">活動性內出血（如消化道出血）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">未控制的高血壓（SBP &gt;180 mmHg）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:#c00000">主動脈剝離疑慮</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<li><h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">急性期藥物治療（MONA-B）</span></h3>
				</li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">縮寫</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">藥物</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">作用</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">M</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Morphine</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">緩解疼痛，減少交感興奮</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">O</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Oxygen</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">僅限於血氧 &lt;90%</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">N</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Nitroglycerin（NTG）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">緩解心絞痛，</span><span style="font-family:Microsoft JhengHei;color:black">但不可用於右心室梗塞</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">A</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Aspirin（300 mg） + P2Y12 受體拮抗劑</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">DAPT（雙重抗血小板治療），如 Clopidogrel、Ticagrelor</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">B</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Beta-blocker</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">減少心肌氧耗，避免再發生心律不整</span></td>
					</tr>
				</tbody></table>
				<br>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">住院與長期治療</span></p>
				<ul>
					<li style="list-style-type:circle"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">藥物治療</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">DAPT（雙重抗血小板治療）</span><span style="font-family:Microsoft JhengHei;color:black">：Aspirin + P2Y12 抑制劑（</span><span style="font-family:Microsoft JhengHei;color:black">至少 12 個月</span><span style="font-family:Microsoft JhengHei;color:black">）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Statin（高強度）</span><span style="font-family:Microsoft JhengHei;color:black">：Atorvastatin 40-80 mg / Rosuvastatin 20-40 mg</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">ACEI / ARB</span><span style="font-family:Microsoft JhengHei;color:black">：減少心臟重塑，預防心衰</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Beta-blocker</span><span style="font-family:Microsoft JhengHei;color:black">：降低猝死風險</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">Aldosterone antagonist（Spironolactone）</span><span style="font-family:Microsoft JhengHei;color:black">：LVEF &lt;40% 或合併心衰患者</span></li>
					</ul>
					</li>
					<li style="list-style-type:circle"><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:black">生活習慣調整</span></p>
					<ul>
						<li><span style="font-family:Microsoft JhengHei;color:black">戒菸</span><span style="font-family:Microsoft JhengHei;color:black">（Smoking cessation）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">控制三高</span><span style="font-family:Microsoft JhengHei;color:black">（高血壓、糖尿病、高血脂）</span></li>
						<li><span style="font-family:Microsoft JhengHei;color:black">規律運動</span><span style="font-family:Microsoft JhengHei;color:black">（適量有氧運動）</span></li>
					</ul>
					</li>
				</ul>
				</li>
				<br>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">特徵</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">UA（不穩定型心絞痛）</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">NSTEMI（非ST段抬高型心肌梗塞）</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">STEMI（ST段抬高型心肌梗塞）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">血管阻塞程度</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">部分阻塞</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">部分阻塞</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">完全阻塞（100%）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">症狀</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">胸痛&lt;30 min</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">胸痛&lt;30 min</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">胸痛&gt;30 min</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">心肌壞死</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">無</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">有</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">有（更嚴重）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">心肌酵素</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">正常</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">上升</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">上升</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ECG 變化</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">可能正常 / ST段depression / T波inversion</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ST段depression/ T波inversion</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ST 段elevation（2 個相鄰導程）</span></td>
					</tr>
					<tr>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">主要治療</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗血小板、抗凝、硝酸鹽</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗血小板、抗凝、β 阻斷劑</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">急診再灌注治療（PCI / tPA）</span></td>
					</tr>
				</tbody></table>
				<li><p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">記憶要點</span></p>
				<ul>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">UA 與 NSTEMI 最大區別：心肌酵素是否上升（NSTEMI↑，UA 正常）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">NSTEMI 與 STEMI 最大區別：ECG 是否 ST 段抬高（STEMI 有，NSTEMI 無）</span></li>
					<li style="list-style-type:circle"><span style="font-family:Microsoft JhengHei;color:black">STEMI 必須緊急再灌注治療（PCI 或溶栓 tPA）</span></li>
				</ul>
				</li>
				<br>
				<li><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">ACS藥物整理</span></li>
				<table style="border:1px solid;border-collapse:collapse">
					<tbody><tr>
						<td style="width:58;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">藥物類別</span></td>
						<td style="width:91;border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">代表藥物</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">作用機制</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">臨床作用</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">副作用</span></td>
						<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">注意事項</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗血小板藥物</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Aspirin</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制COX-1，降低 TXA2 生成</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">減少血小板聚集，預防血栓形成</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">胃潰瘍、出血風險、氣喘（AERD）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">長期使用需注意消化道潰瘍，可與 PPI 併用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><br>
						</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">P2Y12 抑制劑</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">阻斷ADP受體（P2Y12），抑制血小板聚集</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">與 Aspirin 併用（DAPT），預防支架血栓</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">出血、血小板減少症</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">選擇藥物依患者特徵</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">P2Y12 抑制劑</span></p>
						<br>
						</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Clopidogrel</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">不可逆</span><span style="font-family:Microsoft JhengHei;color:black">抑制 P2Y12</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">需肝臟 CYP2C19 代謝，藥效延遲</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">CYP2C19 poor metabolizer 反應較差</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">基因多型性影響藥效，CYP2C19 poor metabolizer 避免使用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">P2Y12 抑制劑</span></p>
						<br>
						</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Prasugrel</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">不可逆</span><span style="font-family:Microsoft JhengHei;color:black">抑制 P2Y12，作用強於 Clopidogrel</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">較 Clopidogrel 更快、更強</span><span style="font-family:Microsoft JhengHei;color:black">，但出血風險高</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">出血風險較高</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">75 歲以上、低體重（&lt;60 kg）、卒中病史禁用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><p style="margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">P2Y12 抑制劑</span></p>
						<br>
						</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Ticagrelor</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">可逆</span><span style="font-family:Microsoft JhengHei;color:black">抑制P2Y12，非前驅藥（直接作用）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">較 Clopidogrel 更快、更強</span><span style="font-family:Microsoft JhengHei;color:black">，不受 CYP2C19 影響</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">呼吸困難（Dyspnea）、高尿酸血症、出血風險</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">需 BID 服用，依從性較差</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗凝劑</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">UFH</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">透過 Antithrombin III 抑制Factor IIa（Thrombin）&amp; Xa</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">速效，PCI 前常用</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">出血、HIT</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">需監測 aPTT，HIT 風險高時避免使用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗凝劑</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Enoxaparin（LMWH）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">主要抑制 </span><span style="font-family:Microsoft JhengHei;color:black">Factor Xa</span><span style="font-family:Microsoft JhengHei;color:black">，部分抑制 Thrombin（IIa）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">半衰期較 UFH 長，皮下注射給藥</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">出血、腎功能不佳者需調整劑量</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">肌酐清除率（CrCl）&lt;30 mL/min 時調整劑量</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抗凝劑</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Bivalirudin</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">直接抑制 Thrombin（IIa）</span><span style="font-family:Microsoft JhengHei;color:black">，不經過 Antithrombin</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">可替代 Heparin，降低出血風險</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">出血、腎功能不佳者需調整劑量</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">常用於 HIT 風險高者</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">血管擴張劑</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Nitroglycerin（NTG）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">轉換為NO，活化 cGMP，血管擴張</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">緩解心絞痛、降低心肌耗氧量</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">頭痛、低血壓、反射性心動過速</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">禁忌：使用 PDE5 抑制劑者（如 Sildenafil）</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">β 阻斷劑</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Metoprolol（選擇性 β1 阻斷劑）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制β1受體，減少心肌收縮力與心率</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">降低心肌氧需求，減少猝死風險</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">禁忌：心源性休克、急性心衰竭、嚴重支氣管痙攣</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">合併低血壓或心動過緩者應避免使用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">ACEI</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Enalapril, Ramipril</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制</span><span style="font-family:Microsoft JhengHei;color:black">ACE</span><span style="font-family:Microsoft JhengHei;color:black">，降低 </span><span style="font-family:Microsoft JhengHei;color:black">Angiotensin II</span><span style="font-family:Microsoft JhengHei;color:black"> 生成</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">降低血壓、減少心臟重塑，適用於 LVEF &lt;40% 或糖尿病患者</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">乾咳（ACEI 特有）、高血鉀、低血壓、腎功能惡化</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">腎動脈狹窄患者禁用</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid">ARB</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Losartan, Valsartan</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">阻斷</span><span style="font-family:Microsoft JhengHei;color:black">Angiotensin II AT1 受體</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">作用類似 ACEI，但無乾咳副作用</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高血鉀、低血壓、腎功能惡化</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">腎功能不佳患者需監測血鉀</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Statin（HMG-CoA 還原酶抑制劑）</span></td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Atorvastatin 40–80 mg</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">抑制HMG-CoA 還原酶，減少肝臟膽固醇合成，增加 LDL 受體表達</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">顯著降低 LDL-C，穩定斑塊，抗發炎</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">肝酵素上升、肌肉痠痛（myopathy）、橫紋肌溶解（罕見）</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">需監測肝功能及 CK（若有肌肉症狀）</span></td>
					</tr>
					<tr>
						<td style="width:58;border:1px solid">Statin</td>
						<td style="width:91;border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">Rosuvastatin 20–40 mg</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">效力更強的 Statin</span><span style="font-family:Microsoft JhengHei;color:black">，類似 Atorvastatin</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">高強度降脂，適用於 ACS 患者</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">腎功能不佳者須調整劑量</span><span style="font-family:Microsoft JhengHei;color:black">，類似 Atorvastatin副作用</span></td>
						<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">CrCl &lt;30 mL/min 時，建議減量</span></td>
					</tr>
				</tbody></table>
				<br>
				<ol>
					<li style="margin-top:5.5pt;margin-bottom:5.5pt">HARRISON Principles of Internal Medicine 20th Edition</li>
					<li>Boards &amp; Beyonds：STEMI</li>
					<li style="margin-top:5.5pt;margin-bottom:5.5pt"><a href="https://www.tsoc.org.tw/upload/files/acs-39-004-1(1).pdf" style="font-family:Microsoft JhengHei">https://www.tsoc.org.tw/upload/files/acs-39-004-1(1).pdf</a></li>
					<li style="margin-top:5.5pt;margin-bottom:5.5pt"><a href="https://www.tsoc.org.tw/upload/files/2018%20Guidelines%20of%20TSOC_EM%20and%20TSCI%20for%20the%20management%20of%20non%20ST-segment%20elevation%20acute%20coronary%20syndrome(1).pdf" style="font-family:Microsoft JhengHei">https://www.tsoc.org.tw/upload/files/2018%20Guidelines%20of%20TSOC_EM%20and%20TSCI%20for%20the%20management%20of%20non%20ST-segment%20elevation%20acute%20coronary%20syndrome(1).pdf</a></li>
					<li style="margin-top:5.5pt;margin-bottom:5.5pt"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309" style="font-family:Microsoft JhengHei">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309</a></li>
					<li style="margin-top:5.5pt;margin-bottom:5.5pt"><span lang="zh-TW"><a href="https://commons.wikimedia.org/wiki/File:Coronary_vessels,_with_annotated_arteries.svg">https://commons.wikimedia.org/wiki/File:Coronary_vessels,_with_annotated_arteries.svg</a></span></li>
				</ol>
				<br>
			</ul>
			<br>
			<br>
			<br>
			<h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗血小板藥物（Antiplatelet Agents）</span></h4>
			<h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗凝血藥物（Anticoagulants）</span></h4>
			<h4 lang="zh-TW" style="font-size:12pt;color:#2f5496;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:14pt;color:#70ad47;font-weight:bold">抗缺血藥物（Anti-ischemic Therapy）</span></h4>
			<br>
			<br>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">ST段抬高型心肌梗塞（STEMI）</span></h3>
			<br>
			<br>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">Cardiac biomarker重點：</span></h3>
			<br>
			<h2 lang="zh-TW" style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">冠狀動脈解剖</span></h2>
			<br>
			<h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;color:black">主要血管分佈</span></h2>
			<br>
			<br>
			<h2 style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:black">下壁STEMI 進一步分析（國考常考）</span></h2>
			<br>
			<h2 lang="zh-TW" style="font-size:14pt;color:#2e75b5;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">STEMI急性治療（國考考點）</span></h2>
			<br>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">再灌流策略（PCI vs. 溶栓）</span></h3>
			<br>
			<table style="border:1px solid;border-collapse:collapse">
				<tbody><tr>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">步驟</span></td>
					<td style="border:1px solid;text-align:center"><span style="font-family:Microsoft JhengHei;color:black">時間目標</span></td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">到院後 10 分鐘內（Door-to-ECG）</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">完成 </span><span style="font-family:Microsoft JhengHei;color:black">12 導程 ECG</span><span style="font-family:Microsoft JhengHei;color:black">，確認 STEMI 診斷</span></td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">到院後 30 分鐘內（Door-to-Needle）</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">若適用 </span><span style="font-family:Microsoft JhengHei;color:black">tPA（血栓溶解劑）</span><span style="font-family:Microsoft JhengHei;color:black">，應完成投藥</span></td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">到院後 90 分鐘內（Door-to-Balloon）</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">若適用 </span><span style="font-family:Microsoft JhengHei;color:black">Primary PCI</span><span style="font-family:Microsoft JhengHei;color:black">，應完成 </span><span style="font-family:Microsoft JhengHei;color:black">氣球擴張</span></td>
				</tr>
				<tr>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">轉院病人（Door-to-Balloon）</span></td>
					<td style="border:1px solid"><span style="font-family:Microsoft JhengHei;color:black">需在 </span><span style="font-family:Microsoft JhengHei;color:black">120 分鐘內完成 PCI</span></td>
				</tr>
			</tbody></table>
			<br>
			<h3 lang="zh-TW" style="font-size:12pt;color:#1f3763;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Microsoft JhengHei;font-size:16pt;color:#1e4e79">急性期藥物治療（MONA-B）</span></h3>
			<br>
			<br>
			<br>
			<br>
			<p style="margin-top:5.5pt;margin-bottom:5.5pt"><span style="font-family:Microsoft JhengHei;color:black">REFERENCE：</span></p>
			<br>
		</div>
	

</body></html>
</div>
      </div>
    </div>
  </div>
  <script>
    if ('serviceWorker' in navigator) {
      window.addEventListener('load', function () {
        navigator.serviceWorker.register('/service-worker.js');
      });
    }
  </script>
</body>
</html>